4-Cyano-2-azetidinones and production thereof

Abstract

4-Cyano-2-azetidinone derivatives represented by the formula ##STR1## wherein R 1 is an amino group which may be acylated or protected, X is a hydrogen atom or a methoxy group and W is a hydrogen atom or a sulfo group, and methods of producing the same, for example, as represented by ##STR2## wherein R 2 is an acylated or protected amino group, Y is a halogen atom or a group having the formula --OCOR 3 , --SCOR 3 or --S(O) n --R 3 (R 3 being a hydrocarbyl group and n an integer 1 or 2), R 4 is an amino group which may be acylated or protected and X is as defined above. Compounds [I] are useful as advantageous intermediates for the synthesis of optically active 4-substituted-2-azetidinone derivatives, and, when W=SO 3 H, [I] are also useful as antimicrobial agents and as beta-lactamase inhibitors.

What we claim is: 
     
       1. A 4-cyano-2-azetidinone compound of the formula ##STR27## wherein X is hydrogen atom or methoxy; and R 1  is (1) amino, (2) an acylated amino group wherein the acyl moiety is (A) a group of the formula:   R.sup.5 --CO.sub.13        wherein R 5  is lower alkyl other than C 1-5  alkyl-CH 2  --, phenyl* or heterocyclic* group;   (B) a group of the formula: ##STR28##  wherein R 6  is hydrogen, amino acid residue*, amino-protecting group or a group R 8  --(CH 2 ) m  --CO--wherein R 8  is heterocyclic*, phenyl* or lower alkyl*; m is an integer of 0 to 3; R 7  is hydrogen, lower alkyl*, phenyl*, heterocyclic* or cycloalkenyl*;   (C) a group of the formula:   R.sup.9 --R.sup.10 --CO--        wherein R 9  is a group ##STR29##  wherein R 11  is heterocyclic* or phenyl*; R 12  is hydrogen, phenyl*, lower acyl or lower alkyl or a group --R 13  --R 14  where R 13  is lower alkylene or lower alkenylene and R 14  is carboxyl or esterified carboxyl; R 10  is a direct bond or a group ##STR30##  wherein R 15  is lower alkyl or heterocyclic*; (D) a group of the formula: ##STR31##  wherein R 16  is halogen, hydroxy, carboxyl, sulfo, formyloxy or azido; R 17  is hydrogen, halogen, lower alkyl, lower alkoxy or hydroxy; or   (E) a group of the formula:   R.sup.18 --R.sup.19 --CH.sub.2 --CO--        wherein R 18  is cyano, phenyl*, phenoxy*, lower alkyl*, alkenyl* or heterocyclic*; R 19  is a direct bond or --S--; and, in the symbols R 5  through R 19 , (a) the lower alkyl is a C 1-6  alkyl,   (b) the lower alkoxy is a C 1-6  alkoxy,   (c) the alkenyl group contains 2-4 carbon atoms,   (d) the cycloalkenyl is of 5- or 6-carbon atoms,   (e) the lower alkylene contains 1-3 carbon atoms,   (f) the lower alkenylene contains up to 3 carbon atoms,   (g) the halogen atom is chlorine, bromine, iodine or fluorine,   (h) the heterocyclic group is 2- or 3-pyrrolyl, 2- or 3-furyl, 2- or 3-thienyl, 2- or 3-pyrrolidinyl, 2-, 3- or 4-pyridyl, N-oxido-2-, 3- or 4-pyridyl, 2-, 3- or 4-piperidinyl, 2-, 3- or 4-pyranyl, 2-, 3- or 4-thiopyranyl, pyrazinyl, 2-, 4- or 5-thiazolyl, 2-, 4- or 5-oxazolyl, 3-, 4- or 5-isothiazolyl, 3-, 4- or 5-isoxazolyl, 2-, 4- or 5-imidazolyl, imidazolidinyl, 3-, 4- or 5-pyrazolyl, pyrazolidinyl, 3- or 4-pyridazinyl, N-oxido-3- or 4-pyridazinyl, 2-, 4- or 5-pyrimidinyl, N-oxido-2-, 4- or 5-pyrimidinyl, piperazinyl, 4- or 5-(1,2,3-thiadiazolyl), 3- or 5-(1,2,4-thiadiazolyl), 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl), 4- or 5-(1,2,3-oxadiazolyl), 3- or 5-(1,2,4-oxadiazolyl), 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,3- or 1,2,4-triazolyl, 1H- or 2H-tetrazolyl, pyrido(2,3-d)pyrimidyl, benzopyranyl, 1,8-, 1,5-, 1,6-, 1,7-, 2,7- or 2,6-naphthyridyl, quinolyl or thieno(2,3-b)pyridyl,   (i) the amino acid residue is glycyl, alanyl, valyl, leucyl, isoleucyl, seryl, threonyl, cysteinyl, cystyl, methionyl, α-, or β-aspartyl, α- or β-glutamyl, lysyl, arginyl, phenylalanyl, phenylglycyl, tyrosyl, histidyl or tryptophyl,   (j) the lower acyl group contains 2-4 carbon atoms,   (k) the group with a superscript asterisk "*" is unsubstituted or substituted with one to three substituents which may be the same or different, wherein the amino, carboxyl and hydroxy group may be protected, thus the substituent of the substituted lower alkyl and of the substituted alkenyl is phenyl, carbamoyl, methylcarbamoyl, carboxy, cyano, halogen or hydroxy, the substituent of the substituted phenyl, phenoxy and cycloalkenyl is C 1-3  alkyl, C 1-3  alkoxy, halogen, amino, benzyloxy, hydroxy, C 2-10  acyloxy, aminomethyl, carbamoylaminomethyl or 3-amino-3-carboxypropoxy, the substituent of the substituted heterocyclic group is C 1-8  alkyl, C 1-3  alkoxy, hydroxy, carboxyl, oxo, monochloroacetamido, aldehyde, trifluoromethyl, amino, halogen, coumarin-3-carbonyl, 4-formyl-1-piperazinyl, pyrrolealdimino, furanaldimino, thiophenealdimino, mesyl, mesylamino-, amino-protecting group, halo-substituted C 2-4  acylamino, phenyl or phenyl substituted with one to three substituents selected from C 1-3  alkyl, C 1-3  alkoxy, halogen, amino, benzyloxy, hydroxy, C 2-10  acyloxy, aminomethyl, carbamoylaminomethyl and 3-amino-3-carboxypropyl, and the substituent of the substituted amino acid residue is amino, amino-protecting group, carbamoyl, methylcarbamoyl or benzyl, or       (3) an amino protected with phthaloyl, p-tert-butylbenzenesulfonyl, benzenesulfonyl, toluenesulfonyl, methanesulfonyl, ethanesulfonyl, succinyl, methoxycarbonyl, ethoxycarbonyl, t-butoxycarbonyl, isopropoxycarbonyl, 2-cyanoethoxycarbonyl, β,β,β-trichloroethoxycarbonyl, β-trimethylsilylethoxycarbonyl, β-methylsulfonylethoxycarbonyl, benzyloxycarbonyl, p-nitrobenzyloxycarbonyl, p-methoxybenzyloxycarbonyl, di-phenylmethyloxycarbonyl, methoxymethyloxycarbonyl, acetylmethyloxycarbonyl, isobornyloxycarbonyl, phenyloxycarbonyl, trityl, 2-nitrophenylthio, benzylidene, 4-nitrobenzylidene, trialkylsilyl, benzyl or p-nitrobenzyl, or an acid-addition salt thereof.     
     
     
       2. A compound as claimed in claim 1, wherein R 1  is an acylated amino group (2) as defined in claim 1. 
     
     
       3. A compound as claimed in claim 1, wherein R 1  is an acylated amino group, the acyl moiety of which is (A) a group of the formula: ##STR32##  wherein R 7'  and R 8'  are heterocyclic* groups; or (B) a group of the formula: ##STR33##  wherein R 11'  is a heterocyclic* group and R 12'  is lower alkyl; and in symbols R 7'  and R 8'  and R 11'  the heterocyclic group is as defined in claim 1 in symbol R 12'  the lower alkyl is a C 1-6  alkyl, and the group with a superscript asterisk "*" is unsubstituted or substituted with one to three substituents selected from C 1-8  alkyl, C 1-3  alkoxy, hydroxy, carboxyl, oxo, monochloroacetamido, aldehyde, trifluoromethyl, amino, halogen, coumarin-3-carbonyl, 4-formyl-1-piperazinyl, pyrrolealdoimino, furanaldoimino, thiophenealdoimino, mesyl, mesylamino, amino-protecting group, halo-substituted C 2-4  acylamino, phenyl or phenyl substituted with one to three substituents selected from C 1-3  alkyl, C 1-3  alkoxy, halogen, amino, benzyloxy, hydroxy, C 2-10  acyloxy, aminomethyl, carbamoylaminomethyl and 3-amino-3-carboxypropyl.   
     
     
       4. A compound as claimed in claim 1, wherein the cyano group has cis configuration to the group R 1  having β-configuration to the azetidine ring. 
     
     
       5. A compound as claimed in claim 1, which is 4-cyano-3-tritylamino-2-azetidinone. 
     
     
       6. A compound as claimed in claim 1, which is 3-amino-4-cyano-2-azetidinone. 
     
     
       7. A compound as claimed in claim 5, which has (3S, 4RS) configuration. 
     
     
       8. A compound as claimed in claim 6, which has (3S, 4R) configuration. 
     
     
       9. A compound as claimed in claim 6, which has (3S, 4S) configuration.